Biologics in COPD: Why, when, and who
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA
